Showing 1 - 2 results of 2 for search 'Keshu Zhou', query time: 0.01s Refine Results
  1. 1
    Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting

    Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting by Qing Zhang, Yongping Song, Keshu Zhou, Quande Lin

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 studyResearch in context

    Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 studyResearch in contex... by Junning Cao, Guangliang Chen, Lihua Qiu, Liling Zhang, Ming Jiang, Ying Cheng, Qiaohua Zhang, Lihong Liu, Ping Li, Yuerong Shuang, Huaqing Wang, Hongwei Xue, Huijing Wu, Meifang Zheng, Keshu Zhou, Zhiming Li, Hongmei Jing, Wei Yang, Zunmin Zhu, Wenyu Li, Jiaxuan Wangwu, Heyu Huang, Qiantao Jia, Dongmei Chen, Songhua Fan, M. Ming Shi, Weiguo Su

    Published 2025-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: